Biostar Pharmaceuticals (Biostar Pharmaceuticals) Short-Term Debt : $2.43 Mil (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals Short-Term Debt?

Biostar Pharmaceuticals's Short-Term Debt for the quarter that ended in Sep. 2017 was $2.43 Mil.

Biostar Pharmaceuticals's quarterly Short-Term Debt increased from Mar. 2017 ($2.34 Mil) to Jun. 2017 ($2.38 Mil) and increased from Jun. 2017 ($2.38 Mil) to Sep. 2017 ($2.43 Mil).

Biostar Pharmaceuticals's annual Short-Term Debt declined from Dec. 2014 ($3.10 Mil) to Dec. 2015 ($2.77 Mil) and declined from Dec. 2015 ($2.77 Mil) to Dec. 2016 ($2.33 Mil).

Biostar Pharmaceuticals Short-Term Debt Historical Data

The historical data trend for Biostar Pharmaceuticals's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostar Pharmaceuticals Short-Term Debt Chart

Biostar Pharmaceuticals Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Short-Term Debt

Get a 7-Day Free Trial

6.34

3.10

2.77

2.33

Biostar Pharmaceuticals Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Short-Term Debt	Get a 7-Day Free Trial															2.42	2.33	2.34	2.38	2.43

Biostar Pharmaceuticals Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Biostar Pharmaceuticals Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046

Website

http://www.biostarpharmaceuticals.com

Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines

From GuruFocus

Biostar Pharmaceuticals Announces Receipt of Additional Delisting Determination Letter from Nasdaq

By Marketwired Marketwired • 08-23-2018

Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice

By PRNewswire PRNewswire • 04-23-2018